3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
pembrolizumab
139
Cisplatin
76
Cetuximab
53
Carboplatin
49
Paclitaxel
39
Nivolumab
39
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
tislelizumab
9
Biopsy
9
durvalumab
8
Radiosurgery
8
Albumin-Bound Paclitaxel
8
130-nm albumin-bound paclitaxel
8
Standard of Care
7
Chemoradiotherapy
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Fibroblast Growth Factor 7
×
1 year
×
Clear all
No trials found.